Hussman Strategic Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Hussman Strategic Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,200	Closed	-$172K	–	404
2021 Q1	$172K	Sell	7,200 -28,550	-80%	-$531K	0.04%	314
2020 Q4	$522K	Hold	35,750	–	–	0.14%	227
2020 Q3	$508K	Buy	+35,750	New	+$546K	0.13%	211

Hussman Strategic Advisors's GNMK Position: Q2 2021 in Review

Hussman Strategic Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 7,200 shares — an estimated $172K sold.

Hussman Strategic Advisors first reported a position in GNMK in Q3 2020 and held it in 3 quarters. The position peaked at $522K in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Hussman Strategic Advisors reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Hussman Strategic Advisors sold 7,200 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $172K.
Hussman Strategic Advisors first reported a position in GenMark Diagnostics, Inc in Q3 2020 and held it in 3 quarters.
Hussman Strategic Advisors's GenMark Diagnostics, Inc position peaked at $522K in Q4 2020.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Hussman Strategic Advisors's 13F filing for Q2 2021, filed 3 Aug 2021.